In vitro studies demonstrated that IFNα-2b-loaded hydrogels could sensitize T cells against gastric cancer cells, involving the upregulation of the early activation marker CD69 and the secretion inflammatory cytokine-IFNγ. Here, IFNA2 is linked to gastric cancer.